Comparative study of Haridradi Parisheka and Moxifloxacin eye drop in anjananamika i. e stye

Randomised comparative clinical trial to study the effect of Haridradi Parisheka and Moxifloxacin 0.5% eye drop in Anjannamika.

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023619

Enrollment

Registered

2020-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H000- Hordeolum (externum) (internum) ofeyelid

Interventions

Intervention1: Haridradi Parisheka: Parisheka(stream) of Haridradi decoction will be poured on affected eye for 5-10 min once a day Control Intervention1: Moxifloxacin 0.5% eye drop: One drop thrice a

Eligibility

Inclusion criteria

Inclusion criteria: 1.patients having signs and symptoms of Anjannamika 2.patients irrespective of gender and religion. 3.patients of age group 19-50 years

Exclusion criteria

Exclusion criteria: 1.patients having active systemic disease,auto immune disease acute respiratory distress or other febrile conditions etc 2. Patients having any corneal involvement,uveitis,conjunctivitis,any structural eye deformiity. 3.patient not willing for trial.

Design outcomes

Primary

Measure	Time frame
A comparative clinical trial to study the efficasy of Haridradi Parisheka and Moxifloxacin 0.5% eye drop in Anjannamika i.e. Stye.Timepoint: 3 weeks	—

Secondary

Measure	Time frame
Cure of Anjannamika and reduced recurrenceTimepoint: 18 months	—

Countries

India

Contacts

Public ContactVd Darshan Chandrakant Dhage

Sumatibhai Shah Ayurved Mahavidyalaya, Hadapsar, pune

drnspradhan@yahoo.com9423580963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026